Product
mRNA-1010.6
1 clinical trial
1 indication
Indication
InfluenzaClinical trial
A Phase 2, Randomized, Active-Controlled, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults 18 to 49 Years of AgeStatus: Completed, Estimated PCD: 2023-12-19